Health & Medicine
23andMe Responds to FDA, Halts Health Analysis of Genetic Results - For Now
Genetic test maker 23andMe issued a statement Thursday announcing its decision to stop offering its signature service while the company goes forward with the Food and Drug Administration's (FDA) review processes surrounding it.
Latest Research Articles
Skin 'Talks' to the Liver [VIDEO]
FDA Okays Gilead's $1,000-a-day Drug for Hepatitis C
Gut Bacteria Linked with Colorectal Cancer
Mindful Meditation Reduces Stress by Altering Gene Expression, Study Finds
FDA Approves Xiaflex for Peyronie’s disease
Healthy Diet Costs $550 More per Year: Harvard Study
Poor Brain Wiring Behind Dyslexia
Nerves in Stomach Control Eating Habits
Infants Exposed to Loud Music, Seizures could have Poor Brain Development
Dementia Cases to Reach 135 Million by 2050
Depression in Pregnant Women May Affect Babies' Brain Development
Exercise May Boost Cognitive Function in People with Dementia




